The role of omalizumab in the treatment of severe allergic asthma

BACKGROUND: A novel anti-immunoglobulin E (anti-IgE) therapy for asthma, omalizumab, has been approved for use in Canada. OBJECTIVE: To review the basic and clinical data for omalizumab, and to examine its possible role for asthma management in Canada. METHODS: A literature search from 1960 to 2006...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Chapman, Kenneth R, Cartier, Andre, Hébert, Jacques, McIvor, R Andrew, Schellenberg, R Robert
Format: Artigo
Jezik:Inglês
Izdano: Pulsus Group Inc 2006
Teme:
Advisory Board Meeting Supplement
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2806789/
https://ncbi.nlm.nih.gov/pubmed/16909166
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki